×

CellRapeutics™ Leukopak from Asthma Donor (XS-0426-XU228)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with clinical asthma, this Leukopak captures the cellular heterogeneity of airway hyperresponsiveness at a systemic level. The cell population is characterized by distinct patterns of leukocyte activation and recruitment markers associated with bronchial inflammation. It is ideal for large-scale studies on the genetic and epigenetic regulation of Th2/Th17 cells and the development of novel inhaled or systemic immunotherapies.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Leukopak from Asthma Donor
  • Cat. No.
  • XS-0426-XU228
  • Donor Age
  • Young Adult, Middle-Aged
  • Donor Health
  • Leukocytes reflect chronic airway-driven immune activation, showing distinct cytokine secretion patterns and specific leukocyte recruitment markers associated with bronchial hyperresponsiveness.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Acid Citrate Dextrose, prioritized to maintain the functional state of Th2 cells and eosinophil integrity without triggering non-specific degranulation.
  • Additional Donor Information
  • Each lot features a Leukopak from donors with clinical asthma. Profiles include FEV1/FVC ratios and medication use, enabling large-scale study of airway-driven immune cells.
  • Clinical Profile
  • Severity classification, smoking history, and history of corticosteroid inhaler use.

Additional Information

  • Medication History
  • Available upon request. Includes history of inhaled corticosteroids, long-acting beta-agonists, and any use of biological therapies targeting IgE or interleukins.
  • Formulation
  • Cryopreserved or Fresh options available.
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.
  • Storage
  • Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • Full Bag, Half Bag
  • Keywords
  • CellRapeutics™ Leukopak from Asthma Donor, Leukopak, Asthma

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Asthma Donor (XS-0426-XU228). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.